Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 2Obesity 1Adenocarcinoma of Lung 1

Interventions

Metformin 152Clomiphene 52Letrozole 41Inositol 34Folic Acid 18Progesterone 17Exercise 17Ethinyl Estradiol 13Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Contraceptives, Oral 12cetrorelix 11Pioglitazone 10High-Intensity Interval Training 10Cholecalciferol 10Triptorelin Pamoate 9Tablets 9Spironolactone 9Menotropins 8Diet 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7follitropin alfa 6drospirenone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Orlistat × Clear all
NCT01003483 2021-04-01

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

Yazd Research & Clinical Center for Infertility

Phase 2 Completed
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT00704912 2016-11-07

OWL-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
217 enrolled 16 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡